Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer

Deepthi Telikicherla, Arivusudar Marimuthu, Manoj Kumar Kashyap, Y. L. Ramachandra, Sujatha Mohan, Juan Carlos Roa, Jagadeesha Maharudraiah, Akhilesh Pandey

Research output: Contribution to journalArticle

Abstract

The molecular events that lead to malignant transformation and subsequent metastasis of breast carcinoma include alterations in the cells at genome, transcriptome and proteome levels. In this study, we used publicly available gene expression databases to identify those candidate genes which are upregulated at the mRNA level in breast cancers but have not been systematically validated at the protein level. Based on an extensive literature search, we identified ribosome binding protein 1 (RRBP1) as a candidate that is upregulated at the mRNA level in five different studies but its protein expression had not been investigated. Immunohistochemical labeling of breast cancer tissue microarrays was carried out to determine the expression of RRBP1 in a large panel of breast cancers. We found that RRBP1 was overexpressed in 84% (177/219) of breast carcinoma cases tested. The subcellular localization of RRBP1 was mainly observed to be in the cytoplasm with intense staining in the perinuclear region. Our findings suggest that RRBP1 is an interesting molecule that can be further studied for its potential to serve as a breast cancer biomarker. This study also demonstrates how the integration of biological data from available resources in conjunction with systematic evaluation approaches can be successfully applied to clinical proteomics.

Original languageEnglish (US)
Article number7
JournalClinical Proteomics
Volume9
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Ribosomes
Carrier Proteins
Genes
Breast Neoplasms
Messenger RNA
Proteome
Microarrays
Tumor Biomarkers
Gene expression
Labeling
Proteins
Tissue
Molecules
Transcriptome
Proteomics
Cytoplasm
Genome
Databases
Staining and Labeling
Neoplasm Metastasis

Keywords

  • 180 kDa ribosome receptor homolog
  • Biomarker
  • Breast neoplasms
  • Early detection
  • Endoplasmic reticulum membrane protein
  • ES130
  • Immunohistochemistry
  • P180

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry

Cite this

Telikicherla, D., Marimuthu, A., Kashyap, M. K., Ramachandra, Y. L., Mohan, S., Roa, J. C., ... Pandey, A. (2012). Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer. Clinical Proteomics, 9(1), [7]. https://doi.org/10.1186/1559-0275-9-7

Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer. / Telikicherla, Deepthi; Marimuthu, Arivusudar; Kashyap, Manoj Kumar; Ramachandra, Y. L.; Mohan, Sujatha; Roa, Juan Carlos; Maharudraiah, Jagadeesha; Pandey, Akhilesh.

In: Clinical Proteomics, Vol. 9, No. 1, 7, 2012.

Research output: Contribution to journalArticle

Telikicherla, D, Marimuthu, A, Kashyap, MK, Ramachandra, YL, Mohan, S, Roa, JC, Maharudraiah, J & Pandey, A 2012, 'Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer', Clinical Proteomics, vol. 9, no. 1, 7. https://doi.org/10.1186/1559-0275-9-7
Telikicherla D, Marimuthu A, Kashyap MK, Ramachandra YL, Mohan S, Roa JC et al. Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer. Clinical Proteomics. 2012;9(1). 7. https://doi.org/10.1186/1559-0275-9-7
Telikicherla, Deepthi ; Marimuthu, Arivusudar ; Kashyap, Manoj Kumar ; Ramachandra, Y. L. ; Mohan, Sujatha ; Roa, Juan Carlos ; Maharudraiah, Jagadeesha ; Pandey, Akhilesh. / Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer. In: Clinical Proteomics. 2012 ; Vol. 9, No. 1.
@article{ff15988c5efa436ca93a6519298536a1,
title = "Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer",
abstract = "The molecular events that lead to malignant transformation and subsequent metastasis of breast carcinoma include alterations in the cells at genome, transcriptome and proteome levels. In this study, we used publicly available gene expression databases to identify those candidate genes which are upregulated at the mRNA level in breast cancers but have not been systematically validated at the protein level. Based on an extensive literature search, we identified ribosome binding protein 1 (RRBP1) as a candidate that is upregulated at the mRNA level in five different studies but its protein expression had not been investigated. Immunohistochemical labeling of breast cancer tissue microarrays was carried out to determine the expression of RRBP1 in a large panel of breast cancers. We found that RRBP1 was overexpressed in 84{\%} (177/219) of breast carcinoma cases tested. The subcellular localization of RRBP1 was mainly observed to be in the cytoplasm with intense staining in the perinuclear region. Our findings suggest that RRBP1 is an interesting molecule that can be further studied for its potential to serve as a breast cancer biomarker. This study also demonstrates how the integration of biological data from available resources in conjunction with systematic evaluation approaches can be successfully applied to clinical proteomics.",
keywords = "180 kDa ribosome receptor homolog, Biomarker, Breast neoplasms, Early detection, Endoplasmic reticulum membrane protein, ES130, Immunohistochemistry, P180",
author = "Deepthi Telikicherla and Arivusudar Marimuthu and Kashyap, {Manoj Kumar} and Ramachandra, {Y. L.} and Sujatha Mohan and Roa, {Juan Carlos} and Jagadeesha Maharudraiah and Akhilesh Pandey",
year = "2012",
doi = "10.1186/1559-0275-9-7",
language = "English (US)",
volume = "9",
journal = "Clinical Proteomics",
issn = "1542-6416",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer

AU - Telikicherla, Deepthi

AU - Marimuthu, Arivusudar

AU - Kashyap, Manoj Kumar

AU - Ramachandra, Y. L.

AU - Mohan, Sujatha

AU - Roa, Juan Carlos

AU - Maharudraiah, Jagadeesha

AU - Pandey, Akhilesh

PY - 2012

Y1 - 2012

N2 - The molecular events that lead to malignant transformation and subsequent metastasis of breast carcinoma include alterations in the cells at genome, transcriptome and proteome levels. In this study, we used publicly available gene expression databases to identify those candidate genes which are upregulated at the mRNA level in breast cancers but have not been systematically validated at the protein level. Based on an extensive literature search, we identified ribosome binding protein 1 (RRBP1) as a candidate that is upregulated at the mRNA level in five different studies but its protein expression had not been investigated. Immunohistochemical labeling of breast cancer tissue microarrays was carried out to determine the expression of RRBP1 in a large panel of breast cancers. We found that RRBP1 was overexpressed in 84% (177/219) of breast carcinoma cases tested. The subcellular localization of RRBP1 was mainly observed to be in the cytoplasm with intense staining in the perinuclear region. Our findings suggest that RRBP1 is an interesting molecule that can be further studied for its potential to serve as a breast cancer biomarker. This study also demonstrates how the integration of biological data from available resources in conjunction with systematic evaluation approaches can be successfully applied to clinical proteomics.

AB - The molecular events that lead to malignant transformation and subsequent metastasis of breast carcinoma include alterations in the cells at genome, transcriptome and proteome levels. In this study, we used publicly available gene expression databases to identify those candidate genes which are upregulated at the mRNA level in breast cancers but have not been systematically validated at the protein level. Based on an extensive literature search, we identified ribosome binding protein 1 (RRBP1) as a candidate that is upregulated at the mRNA level in five different studies but its protein expression had not been investigated. Immunohistochemical labeling of breast cancer tissue microarrays was carried out to determine the expression of RRBP1 in a large panel of breast cancers. We found that RRBP1 was overexpressed in 84% (177/219) of breast carcinoma cases tested. The subcellular localization of RRBP1 was mainly observed to be in the cytoplasm with intense staining in the perinuclear region. Our findings suggest that RRBP1 is an interesting molecule that can be further studied for its potential to serve as a breast cancer biomarker. This study also demonstrates how the integration of biological data from available resources in conjunction with systematic evaluation approaches can be successfully applied to clinical proteomics.

KW - 180 kDa ribosome receptor homolog

KW - Biomarker

KW - Breast neoplasms

KW - Early detection

KW - Endoplasmic reticulum membrane protein

KW - ES130

KW - Immunohistochemistry

KW - P180

UR - http://www.scopus.com/inward/record.url?scp=84901842728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901842728&partnerID=8YFLogxK

U2 - 10.1186/1559-0275-9-7

DO - 10.1186/1559-0275-9-7

M3 - Article

AN - SCOPUS:84901842728

VL - 9

JO - Clinical Proteomics

JF - Clinical Proteomics

SN - 1542-6416

IS - 1

M1 - 7

ER -